Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Guozhe Xian

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5109079778. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 6

  1. Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Le… Co-author DOI 10.1016/j.canlet.2022.215739↗
  2. [Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2020.5157↗
  3. TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer. Last author DOI 10.1016/j.yexcr.2019.111713↗
  4. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis. Co-author DOI 10.1016/j.canlet.2016.11.006↗
  5. Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2017.4099↗
  6. Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis. Co-author DOI 10.1002/bab.1326↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenhai Zhang · 5 shared papers, 2017–2022 · strength 0.59
  2. Chengkun Qin · 5 shared papers, 2015–2022 · strength 0.54
  3. Zhiyi Wang · 3 shared papers, 2017–2021 · strength 0.33
  4. Xinxing Wang · 3 shared papers, 2017–2021 · strength 0.33
  5. Xianping Cui · 3 shared papers, 2015–2021 · strength 0.27
  6. Zhongxue Su · 2 shared papers, 2017–2022 · strength 0.27
  7. Xin Liu · 1 shared paper, 2015 · strength 0.06
  8. Xingsong Tian · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.